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Total cholesterol was measured and Low-Density Lipoprotein Cholesterol
(LDL-C) was calculated using the Friedewald formula. CVD risk in those
without CVD or diabetes was calculated using the Systematic Coronary
Risk Estimation (SCORE) ‘low’ risk country equations.2
Hypercholesterolaemia was defined as a LDL-C in excess of the
recommended CVD risk category target as outlined in the European
Society of Cardiology guidelines (Table 1)3 and/or on lipid lowering
medication (LLM).
Results
The household response rate to the baseline TILDA survey was 62%. Of
the 8175 adults who participated, 7537 were aged between 50 and 79
years. Of these, 70.1% (n=5287) took part in the health assessment and
had complete risk factor data available for analysis. Those excluded from
the analysis had less favourable risk factor profiles.4
Findings reveal a weighted mean TC of 5.1 mmol/L (95% CI 5.0-5.1
mmol/L) and a mean LDL-C of 2.9 mmol/L (95% CI 2.8-2.9 mmol/L) in
those aged 50-79 years. LLM was used by 33.9% (95% CI 32.3-35.4%).
In those not on LLM the weighted mean TC and LDL-C peaked in men
aged 55-59 years and in women aged 60-64 years (Figure 1).
Introduction
Raised serum cholesterol is an important modifiable risk factor for the
development of cardiovascular disease (CVD). A reduction in total
cholesterol of 1 mmol/L is associated with a 33% reduction in ischaemic
heart disease mortality in those aged 50-69 years and a 17% reduction in
those aged 70-89 years.1
The aim of this study is to describe the distribution of serum cholesterol in
a community living population of older adults in Ireland aged 50-79 years
and to examine the awareness, treatment and control of
hypercholesterolaemia in a subgroup aged 50-64 years according to their
CVD risk status.
Examination of those with 
hypercholesterolaemia (n=2357) 
revealed a varied picture in relation to 
awareness, treatment and control of 
LDL-C according to disease status 
and SCORE risk category (Figure 2). 
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Figure 2: Awareness treatment and control of hypercholesterolaemia according to 
cardiovascular disease and SCORE risk stratification (TILDA, wave1, 50-64 years).
Figure 1: Weighted mean total cholesterol and LDL cholesterol according to sex, age group and 
lipid-lowering medication status (TILDA wave 1, 50-79 years, n=5287)
Conclusion
Despite a substantial reduction in population mean TC from a high of 
6.0 mmol/L (aged 35-64 yrs)5 in the 1980s to 5.1 mmol/L, this study 
reports a failure to control hypercholesterolaemia to recommended 
CVD risk stratified targets in the Irish adult population. In known high 
risk groups (CVD or Diabetes) opportunities are being missed to 
achieve LDL-C control as recommended in clinical guidelines. In the 
primary prevention category lack of awareness of 
hypercholesterolaemia was high across all risk stratified groups.
Recommendations for policy include continued monitoring of those at 
highest risk and CVD risk assessment in those perceived to be at low 
risk in order to inform shared decision making in relation to lifestyle 
modification and medication management.  
Methods
This study uses nationally representative cross-
sectional data from the baseline wave (2009-2011)
of the Irish Longitudinal Study on Ageing (TILDA).
Home-based interviews and health assessments
were conducted. Self-report of a doctor’s diagnosis
of CVD and diabetes and smoking status were
recorded. Non-fasting blood was drawn and blood
pressure was measured during the health
assessment.
Table 1:  LDL-C targets according to 
disease status or CVD risk 3
A high proportion of participants 88.9% (CI 87.8-89.9%) reported ever 
having a blood test for cholesterol. Almost half of those aged 50-79 years 
(44.8%, 95% CI 43.3-46.3%) had a TC <5mmol/L and just over half 
(51.3%, 95% CI 49.8-52.8%) had an LDL-C <3mmol/L.
In the subgroup aged 50-64 years (n=3227), 73% (95% CI 71.5-74.5%) 
were hypercholesterolaemic. 
